ear-infrared fluorescence imaging in kidney transplantations using ZW800-1 for perfusion assessment: a pilot study

eiden University Medical Center0 个研究点目标入组 20 人开始时间: 2018年7月3日最近更新: 2019年11月25日

适应症

试验速览

暂无简介。

•1) Patients > 18 years old;
•2) Patient couples scheduled for a living donor nephrectomy and kidney transplantation;
•3) Patients should be capable and willing to give informed consent before study specific procedures;
•4) No unacceptable known cardiovascular or pulmonary disease, renal or liver dysfunction;
•5) The screening ECG and laboratory test results are within normal limits, or if any are outside of normal limits they are considered to be clinically insignificant;
•6) Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 20
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 20

•1) History of a clinically significant allergy or anaphylaxis;
•2) Patients who previously underwent a kidney transplantation;
•3) Patients pregnant or breastfeeding, lack of effective contraception in male or female patients with reproductive potential;
•4) Any condition that the investigator considers to be potentially jeopardizing the patients well-being or the study objectives.

发起方

eiden University Medical Center